Vera Cvoro
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease-Outcomes at 6 Months in the LACI-2 Randomized Controlled Trial.
Journal: Journal of the American Heart Association
Published: July 31, 2026
Stroke, Small-Vessel Disease, and Occupation: Systematic Review and Data Analysis.
Journal: Journal of the American Heart Association
Published: January 30, 2026
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial.
Journal: PloS one
Published: May 14, 2024
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial.
Journal: PloS one
Published: May 30, 2023
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial.
Journal: JAMA neurology
Published: May 24, 2023
Understanding the performance and reliability of NLP tools: a comparison of four NLP tools predicting stroke phenotypes in radiology reports.
Journal: Frontiers in digital health
Published: March 12, 2023
Research protocol - Assessing Post-Stroke Psychology Longitudinal Evaluation (APPLE) study: A prospective cohort study in stroke.
Journal: Cerebral circulation - cognition and behavior
Published: November 23, 2021
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.
Journal: Journal of cachexia, sarcopenia and muscle
Published: July 16, 2021
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease.
Journal: European stroke journal
Published: January 20, 2020
Last Updated: 09/26/2026